Insider Transactions in Q4 2024 at Bio Cardia, Inc. (BCDA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2024
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
250
+0.24%
|
$500
$2.22 P/Share
|
|
Nov 15
2024
|
Peter Altman President and CEO |
BUY
Open market or private purchase
|
Direct |
1,350
+1.27%
|
$1,350
$1.87 P/Share
|
|
Oct 11
2024
|
David Mc Clung Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,565
-27.82%
|
$23,130
$2.65 P/Share
|
|
Oct 11
2024
|
David Mc Clung Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,193
+36.79%
|
$48,386
$2.65 P/Share
|
|
Oct 11
2024
|
Peter Altman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,680
-17.25%
|
$43,360
$2.65 P/Share
|
|
Oct 11
2024
|
Peter Altman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,250
+26.04%
|
$88,500
$2.65 P/Share
|
|
Oct 11
2024
|
Edward M Gillis Senior Vice President, Devices |
SELL
Payment of exercise price or tax liability
|
Direct |
6,840
-35.88%
|
$13,680
$2.65 P/Share
|
|
Oct 11
2024
|
Edward M Gillis Senior Vice President, Devices |
SELL
Grant, award, or other acquisition
|
Direct |
15,808
-45.33%
|
$31,616
$2.65 P/Share
|